OPEN END-TURBO-OPTIONSSCHEIN - KENVUE Stock

Certificat

DE000HS2GTB1

Real-time BOERSE MUENCHEN 15:35:01 2024-07-01 EDT
4.78 EUR -3.63% Intraday chart for OPEN END-TURBO-OPTIONSSCHEIN - KENVUE
1 month-17.61%
3 months-39.29%
Date Price Change
24-07-01 4.78 -3.63%
24-06-28 4.96 -6.42%
24-06-27 5.3 -1.67%
24-06-26 5.39 -0.92%
24-06-25 5.44 -4.56%

Real-time BOERSE MUENCHEN

Last update July 01, 2024 at 03:35 pm

More quotes

Static data

Product typeCertificat Turbo
Buy / SellCALL
Underlying KENVUE INC.
Issuer HSBC
WKN HS2GTB
ISINDE000HS2GTB1
Date issued 2023-10-17
Strike 13.06 $
Maturity Unlimited
Parity 1 : 1
Emission price 6.74
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 8.85
Lowest since issue 4.78
Spread 0.16
Spread %3.26%

Company Profile

Kenvue Inc. is one of the world leaders in the design, manufacture and marketing of consumer healthcare products. The group offers products for health, beauty, baby care, oral care, skin care and more. The business is organized around 3 product families: - health products: for the treatment of coughs, colds, allergies, pain, indigestion, constipation, etc. (brands Zyrtec, Benadryl, Zarbee's, Frenadol, Codral, Reactine, Tylenol, Motrin, Calpol, Nicorette, Imodium, Pepcid, Microlax, Daktarin, etc.); - body care products: hair care products, sun protection products, face and body care products, etc. (Neutrogena, Aveeno, Clean&Clear, Lubriderm, Johnsons, Neostrata, OGX, Rogaine brands, etc.); - other: notably oral care, baby care, women's health and wound care products (Listerine, Desitin, Carefree, Stayfree, Band-Aid, Neosporin brands, etc.). Product marketing is assured through direct sales, distributors and the Internet.
Sector
-
More about the company

Ratings for Kenvue Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Consensus: Kenvue Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
18.18 USD
Average target price
22.54 USD
Spread / Average Target
+23.97%
Consensus